OPT313 Hereditary Macular Disorders

Ulster University Course Overview

  • Course Title: OPT313: Ocular Health and Disease II

  • Instructor: Moyra McClure

Learning Outcomes

  1. Eyewear Knowledge: Ability to explain complex ocular diseases and their effects on visual function based on anatomical and physiological understanding.

  2. Diagnosis Skills: Competence in diagnosing ocular diseases from presenting signs and symptoms.

  3. Differential Diagnosis: Utilization of investigative strategies for differential diagnosis of ocular disorders.

  4. Management Skills: Capability to safely manage and refer patients and propose treatments.

Course Content

  • Overview of Macular Dystrophies

  • Patient Journey:

    • History and Symptoms

    • Clinical Tests and Expected Signs

    • Referral Process

    • Outcomes of Ophthalmology Appointments

    • Prognosis

  • Case Discussions and Group Work

What is Macular Dystrophy?

  • Definition: Genetic disorders causing progressive structural changes in the macula.

  • Dystrophy: Non-infectious, often genetic deterioration of a body part.

Understanding Macular Dystrophy

  • Inherited conditions potentially from faulty genes (autosomal dominant/recessive).

  • Can result in waste product accumulation; onset may occur in childhood or adulthood.

  • Less common than age-related macular degeneration.

History and Symptoms

  • Initial Assessment: Optometrists inquire about changes in central vision:

    • Onset (when started?), unilateral or bilateral involvement, etc.

  • Symptoms:

    • Early Stage: Blurry central vision, blind spots, poor light adaptation, photophobia, distortion.

    • Later Stage: Severe central vision loss, inability to see faces or read.

Clinical Tests: Expected Signs

  • Routine Eye Examination: Focus on visual acuity (distance and near), pupillary reactions, detailed assessments including:

    • Dilated fundus assessment, OCT imaging.

  • Visual Acuity Variability: Ranges from 6/12 to 6/60 or worse, may be unilateral or bilateral.

  • Fundus Imaging: Some dystrophies show clear signs, while others may be more subtle.

Referral Process

  • Optometrists cannot definitively diagnose macular dystrophy but can suggest it in referrals.

  • Management for Children (up to 16 years): Refer to pediatric ophthalmologist, providing all findings and necessary imaging.

  • Management for Adults (16+ years): Refer to general ophthalmology, emphasizing urgency based on the findings.

  • Communication with parents should be factual and empathetic, avoiding in-depth diagnoses.

Ophthalmology Appointment Outcomes

  • Hospital Eye Service (HES) assessments include visual acuity, pupillary reactions, imaging, and potentially genetic testing.

  • Review Appointments: Discuss findings, provide support resources, and link genetics for patient/family education.

Prognosis

  • Dependent on the specific type of macular dystrophy diagnosed; can range from slow to rapid vision loss with severe outcomes expected in time.

Case Examples

  • Stargardt's Macular Dystrophy: Most common; characterized by yellow specks in imaging, progressive sight loss, and genetic mutations affecting vitamin A processing in the eye.

  • Cone Dystrophy: Rare vision conditions presenting in early adulthood; photophobia and central blurs typical, with characteristic bulls-eye appearance in fundus imaging.

  • Bests Dystrophy: Typically diagnosed in the 4th to 5th decades, linked to a BEST1 mutation causing subretinal complications.

  • Fundus Flavimaculatus: Rare, presents in 4th to 5th decades with risks similar to Stargardt's.

Research and Group Work

  • Students are encouraged to research additional macular dystrophies and present findings on clinical signs, diagnostic tests, inheritance patterns, epidemiology, and prognosis.

    • Examples of research topics include:

      • Sorsby fundus dystrophy

      • Butterfly macular dystrophy

Conclusion

  • Continued understanding and study of macular dystrophies is essential in ocular health, along with appropriate referral knowledge for patients.